Carnegie Mellon University

Funding Opportunities

McKnight Foundation Technology Awards
Deadline: April 22, 2019
The McKnight Foundation Technology Awards are now accepting 2 page LOIs, with full proposals (if solicited) due 4/22/19. The awards provide $100,000 over 2 years, beginning in August 2019, to advance and enlarge the range of technologies available to the neurosciences. It does not support research based primarily on existing techniques and is not limited.

International Research Collaboration on Drug Abuse and Addiction Research
Deadline: Standard due dates for the R01 grant mechanism
The National Institute on Drug Abuse invites R01 applications for projects. Multiple awards may be made. Eligibility is unrestricted domestically. Standard due dates apply for the R01 grant mechanism. More information regarding PA-18-773 is available at: https://grants.nih.gov/grants/guide/pa-files/PA-18-773.html

Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials
Deadline: Standard due dates for the R34 grant mechanism
The National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism invites R34 applications for projects. Multiple awards may be made. Eligibility is unrestricted domestically. More information regarding PA-18-775 is available at: https://grants.nih.gov/grants/guide/pa-files/PA-18-775.html.

National Institutes of Health: Notice of Interest in Advancing Research about the Effects of Opioids and Opioid Antagonists on the Fetal and Neonatal Brain Development
The purpose of this Notice is to inform the scientific community of the interest of NIDA and NICHD in advancing scientific knowledge about the consequences of opioid agonist or antagonist exposure during pregnancy on embryonic, fetal and post-natal brain and behavioral development, as well as other health outcomes and the mechanisms underlying these consequences. Learn more.

Chan Zuckerberg Initiative: Neurodegeneration Challenge Network
Deadline: Coming Soon
Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and ALS, are a leading cause of disability and death worldwide. To move toward curing, preventing, or managing these diseases by the end of the century, the Chan Zuckerberg Initiative is seeking to support a stronger scientific understanding of neurodegeneration. To stay updated about this funding opportunity from the Chan Zuckerberg Initiative, please sign up for the mailing list.

National Institute on Drug Abuse: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose
Deadline: Applications will be accepted on a continuing basis.
The National Institute on Drug Abuse invites UG3/UH3 applications to fund the Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose. Approximately $10 million may be made available to support up to four awards. Eligibility is unrestricted domestically. Learn more.

Simons Foundation Fellows—SFARI Explorer Awards
Deadline: Rolling 
This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels. The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable. Learn more.

Group Foundation for Advancing Mental Health: Group Therapy Projects
Deadline: Thursday, Nov. 1, 2018
The Group Foundation for Advancing Mental Health invites applications for Group Therapy Projects that advance the most effective and innovative approaches to group therapy education, training, research, and community outreach. Multiple awards of up to $15,000 each may be made. Eligibility requirements are described in the announcement. Learn more.

BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Re-issue of MH-17-250; F32)
Application Receipt Dates: Friday, Dec. 7, 2018; Wednesday, Aug. 7, 2019; Tuesday, Apr. 7, 2020
The purpose of the BRAIN Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the proposed research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training. Learn more.

Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (Re-issue of EB-17-001; R01)
Application Receipt Dates: Tuesday, Dec. 11, 2018
This RFA uses a R01 mechanism to solicit unusually bold and potentially transformative approaches, including proof-of-concept development of brain imaging based on innovative and/or unconventional concepts aimed at revolutionizing the way non-invasive human neuroimaging is conducted. Tools and technologies can span a wide array of approaches including hardware, software, or imaging probes addressing any of the steps of the image acquisition and analysis process. Creative efforts to bridge scales from the micro- to meso- to macro-level in the brain are especially encouraged. Learn more.

Development of Next Generation Human Brain Imaging Tools and Technologies (Re-issue of EB-17-002; U01)
Application Receipt Dates: Tuesday, Dec. 11, 2018
This RFA uses an U01 mechanism to support the full-scale development of novel imaging technologies beyond the proof of concept stage for noninvasive imaging of human brain processes in ways that are currently unachievable in healthy persons. NIH expects successful projects supported under the previous RFAs to be the basis for some of the applications submitted in response to this announcement, but previous support is not a requirement. This FOA supports an open competition for the best ideas for the full development of innovative and compelling new or next-gen non-invasive brain imaging technologies, with the intent of delivering working tools within the time frame of the BRAIN Initiative. Learn more.

BRAIN Initiative to Support Research on the Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research
Standard Due Dates Apply
Multiple entities within NIH invite R41/R42 applications for the BRAIN Initiative to Support Research on the Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research. Multiple awards may be made under each announcement. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R41/R42 grant mechanism. Applications will be accepted via two R41/R42 announcements:

Studies that Test Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD)
Standard Due Dates Apply
The National Institute on Aging invites R41/R42 and R43/R44 applications for Studies that Test Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD). Multiple awards may be made under each announcement. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R41/R42 and R43/R44 grant mechanisms.

Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease
Standard Due Dates Apply
The National Institute on Aging invites R01 and R21 applications for Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease. Specific opportunities include the development of decision-supportive interventions to leverage cognitive, emotional and motivational strengths of these populations; tools to assess decisional capacity; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wills, etc.). Multiple awards are anticipated under each announcement. Program eligibility is unrestricted domestically. Standard due dates apply for the R01 and R21 grant mechanisms.

National Institute of Nursing Research and the National Institute on Aging: Studies on Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia
Standard Due Dates Apply
The National Institute of Nursing Research and the National Institute on Aging invite R01, R15, and R21 applications for Studies on Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia. Multiple awards are anticipated under each announcement. Program eligibility is unrestricted domestically. Standard due dates apply for the R01, R15, and R21 grant mechanisms.

National Institute on Aging: Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD)
Standard Due Dates Apply
The National Institute on Aging invites R41/R42 and R43/R44 applications to advance Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD). Multiple awards may be made under each announcement. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R41/R42 and R43/R44 grant mechanisms.

Research Projects on Autism Spectrum Disorders
Standard Due Dates Apply
Multiple entities within NIH invite R01, R03, and R21 applications for Research Projects on Autism Spectrum Disorders. Multiple awards are anticipated under each announcement. Program eligibility is unrestricted domestically. Standard due dates apply for the R01, R03, and R21 grant mechanisms.

National Institute on Aging: SBIR Awards to Fund Translational Research on Aging
Standard Due Dates Apply
The National Institute on Aging invites R43/R44 application for SBIR Awards to Fund Translational Research on Aging. Approximately $6 million may be made available to support multiple awards under each announcement. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R43/R44 grant mechanism. Applications will be accepted via two R43/R44 announcements:

National Institute on Aging: Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers
Standard Due Dates Apply
The National Institute on Aging invites R41/R42 and R43/R44 applications for research on the Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers. Approximately $2 million may be made available to support multiple awards. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R41/R42 and R43/R44 grant mechanisms.

National Center for Complementary and Integrative Health: Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions
Standard Due Dates Apply
The National Center for Complementary and Integrative Health invites R41/R42 and R43/R44 applications to support the Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions. Multiple awards may be made under each announcement. Program eligibility is restricted to U.S. small businesses. Standard due dates apply for the R41/R42 and R43/R44 grant mechanisms.